These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 32877549

  • 1. Assessing County-Level Vulnerability for Opioid Overdose and Rapid Spread of Human Immunodeficiency Virus and Hepatitis C Infection in South Dakota.
    Wesner CA, Zhang W, Melstad S, Ruen E, Deffenbaugh C, Gu W, Clayton JL.
    J Infect Dis; 2020 Sep 02; 222(Suppl 5):S312-S321. PubMed ID: 32877549
    [Abstract] [Full Text] [Related]

  • 2. County-Level Vulnerability Assessment for Rapid Dissemination of HIV or HCV Infections Among Persons Who Inject Drugs, United States.
    Van Handel MM, Rose CE, Hallisey EJ, Kolling JL, Zibbell JE, Lewis B, Bohm MK, Jones CM, Flanagan BE, Siddiqi AE, Iqbal K, Dent AL, Mermin JH, McCray E, Ward JW, Brooks JT.
    J Acquir Immune Defic Syndr; 2016 Nov 01; 73(3):323-331. PubMed ID: 27763996
    [Abstract] [Full Text] [Related]

  • 3. Assessment of Tennessee's county-level vulnerability to hepatitis C virus and HIV outbreaks using socioeconomic, healthcare, and substance use indicators.
    Vakili J, Sizemore L, Rebeiro PF, Tyndall B, Talley P, Whaley K, Brantley M.
    PLoS One; 2022 Nov 01; 17(8):e0270891. PubMed ID: 35925969
    [Abstract] [Full Text] [Related]

  • 4. Tennessee's In-state Vulnerability Assessment for a "Rapid Dissemination of Human Immunodeficiency Virus or Hepatitis C Virus Infection" Event Utilizing Data About the Opioid Epidemic.
    Rickles M, Rebeiro PF, Sizemore L, Juarez P, Mutter M, Wester C, McPheeters M.
    Clin Infect Dis; 2018 May 17; 66(11):1722-1732. PubMed ID: 29228122
    [Abstract] [Full Text] [Related]

  • 5. Opioid and other drug use and drug-related mortality as indicators of Hepatitis C and Human Immunodeficiency Virus in Oklahoma.
    Wendelboe AM, Naqvi OH, Williams M, Hollen H, McGrew K, Li P, Harris T, Chou AF.
    PLoS One; 2024 May 17; 19(5):e0301442. PubMed ID: 38722958
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data.
    Evans ME, Person M, Reilley B, Leston J, Haverkate R, McCollum JT, Apostolou A, Bohm MK, Van Handel M, Bixler D, Mitsch AJ, Haberling DL, Hatcher SM, Weiser T, Elmore K, Teshale EH, Weidle PJ, Peters PJ, Buchacz K.
    Public Health Rep; 2020 May 17; 135(4):461-471. PubMed ID: 32633599
    [Abstract] [Full Text] [Related]

  • 10. Mitigating the Risk of Infectious Diseases Among Rural Drug Users in Western North Carolina: Results of the Southern Appalachia Test, Link, Care (SA-TLC) Health Care Provider Survey.
    Hurt CB, Carpenter DM, Evon DM, Hennessy CM, Rhea SK, Zule WA.
    J Rural Health; 2020 Mar 17; 36(2):208-216. PubMed ID: 31742771
    [Abstract] [Full Text] [Related]

  • 11. The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions.
    Perlman DC, Jordan AE.
    Curr HIV/AIDS Rep; 2018 Apr 17; 15(2):96-112. PubMed ID: 29460225
    [Abstract] [Full Text] [Related]

  • 12. Prevalence and correlates of co-infection with human immunodeficiency virus and hepatitis C virus in male injection drug users in Iran.
    Hosseini M, SeyedAlinaghi S, Kheirandish P, Esmaeli Javid G, Shirzad H, Karami N, Jahani M, Seyed Ahmadian M, Payvarmehr F, Mohraz M, Emadi Koochak H, McFarland W.
    Arch Iran Med; 2010 Jul 17; 13(4):318-23. PubMed ID: 20597566
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased HIV diagnoses in West Virginia counties highly vulnerable to rapid HIV dissemination through injection drug use: a cautionary tale.
    Bradley H, Hogan V, Agnew-Brune C, Armstrong J, Broussard D, Buchacz K, Burton K, Cope S, Dawson E, De La Garza G, Gerard A, Granado M, Gupta R, Haddy L, Hoffman W, Johnson SD, Kirk N, Lee C, Lyss S, Mark-Carew M, Quilter L, Reynolds P, Rose B, Thompson A, Varella L, Weidle P, White B, Wills D, Young SA, Hoots BE.
    Ann Epidemiol; 2019 Jun 17; 34():12-17. PubMed ID: 30967302
    [Abstract] [Full Text] [Related]

  • 15. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study.
    Liu Y, Liu Y, Zou X, Chen W, Ling L.
    BMJ Open; 2017 Jul 13; 7(7):e015524. PubMed ID: 28710214
    [Abstract] [Full Text] [Related]

  • 16. Determinants of persistent spread of HIV in HCV-infected populations of injecting drug users.
    de Vos AS, van der Helm JJ, Prins M, Kretzschmar ME.
    Epidemics; 2012 Jun 13; 4(2):57-67. PubMed ID: 22664064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.